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Objective: To examine whether the addition of intravenous dexamethasone during total 
knee arthroplasty (TKA) would be effective at reducing postoperative pain scores and 
postoperative opioid consumption.  
Methods: A total of 102 Patients underwent TKA were placed in two groups, 55 subjects 
received intraoperative dexamethasone 8 mg intravenously (treatment group) and 47 did 
not receive dexamethasone at any time during the perioperative period. Comparison was 
made using the 0-10 numeric pain rating scale and the amount of opioids used in each 
group.  
Results: Patients who received dexamethasone required significantly less oral opioids 
compared to the control group. Pain Scores at 24 hours post surgery were significantly 
less for the dexamethasone group compared to the control group. There was no difference 
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between groups in regards to patient controlled analgesic dose or pain scores in the post-
anesthesia care unit, at 12 or 48 hours post surgery.  
Conclusion: A single dose of dexamethasone given intra-operatively significantly 
decreases oral narcotic consumption and decreased pain scores 24 hours postoperatively.  
Dexamethasone appears to be a safe modality to use to control pain in patients 
undergoing TKA.   
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Introduction 
 
Total knee arthroplasty (TKA) is a procedure for the treatment of degenerative joint 
disease of the knee.  Despite advances in surgical and anesthetic technique, many patients 
still suffer from acute pain in the postoperative period.  Many anesthesia modalities and 
medications have been used in various combinations to reduce the amount of pain 
experienced by patients postoperatively.  Standard treatment for pain relief after TKA 
includes the use of opioids.  Other strategies employ a multi-modal approach. 
Single opioid analgesics may not provide effective pain relief for moderate to severe 
pain, and are associated with side effects such as nausea, vomiting, sedation, 
constipation, and/or bleeding.  These adverse side effects alter the patient’s perceived 
surgical outcomes, may increase the hospital stay and financial burden on the patient and 
the medical system.  Dexamethasone is a long acting glucocorticoid that functions as an 
anti-inflammatory, commonly used in the field of orthopedics. Dexamethasone has been 
shown to inhibit peripheral phospholipase, which decreases the pain-aggravating products 
from the cyclooxygenase and lipoxygenase pathways. Also, corticosteroids inhibit 
cytokine gene expression and the release of pro-inflammatory enzymes, bradykinin, and 
neuropeptides from injured nerve terminals, all of which play a role in precipitating pain. 
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Pro-inflammatory mediators such as interleukin 1, 6, and 8, as well as tumor necrosis 
factor, C-reactive protein, and leukocyte adhesion molecules also decreased with the use 
of corticosteroids1. 
The biologic half-life of dexamethasone is 36 to 55 hours, and its effects are most 
apparent in the first 24 to 48 hours. The medication continues to maintain therapeutic 
levels throughout the postoperative period, when inflammation and post-operative pain 
are at their peak levels.  Transmission of pain signals evoked by tissue damage leads to 
sensitization of the peripheral and central pain pathways. Administering dexamethasone 
before the start of the surgical procedure is a concept known as preemptive analgesia. 
Pre-emptive analgesia is a treatment that is initiated before the surgical procedure in 
order to reduce this sensitization, with the ultimate goal of decreased inflammation and 
pain. The current literature shows that preemptive analgesia must include a way of 
modulating the prolonged neuronal input into the spinal cord in the postoperative period 
that is produced by the inflammatory process at the site of tissue damage. Inflammatory, 
metabolic, hormonal, and immune responses to surgery are activated immediately after 
the surgical incision and thus early administration of corticosteroids may be important to 
obtain the full postoperative benefit1.  
The optimal time to administer dexamethasone is debatable; however, some studies 
have found that administration of dexamethasone preoperatively was more effective at 
reducing 24 hour pain scores than intraoperative administration2. It is theorized that 
because the onset of dexamethasone is one to two hours, sufficient time is needed to 
allow for the drug to diffuse across the cell membrane to alter gene transcription and 
protein production2.  
This article is protected by copyright. All rights reserved.
Several studies have shown the use of dexamethasone to be a beneficial adjunct in 
decreasing postoperative pain. A large systematic review of 5796 patients evaluated the 
impact of a single preoperative dose of dexamethasone on postoperative pain. Patients 
who received dexamethasone reported significantly less pain at 24 hours after 
laparoscopic procedures, tonsillectomies, and hysterectomies, but not after abdominal 
surgery or middle ear surgery when compared to those who did not receive 
dexamethasone2. A 10% reduction in opioid consumption was also found at two hours 
post-operatively and a 13% reduction in opioid consumption was seen at 24 hours 
postoperatively2. Several other studies have found similar results in the effectiveness of 
dexamethasone at decreasing postoperative pain in a variety of surgical procedures 
including TKA1,3-7. 
A retrospective chart review determined the effectiveness of 10 mg intraoperative 
intravenous dexamethasone followed by three days of 4 mg oral dexamethasone in 
patients who underwent TKA6. These patients demonstrated significantly lower pain 
scores in the recovery room and decreased opioid dose equivalence throughout the 
hospital stay than those not on the regimen.  That study showed the effectiveness of a 
multi-dose dexamethasone regimen in producing postoperative analgesia in patients 
undergoing TKA, however, the current authors are interested in the efficacy of a single 
dose of dexamethasone given intra-operatively. 
The purpose of this study is to examine whether the administration of a single dose of 
dexamethasone intravenously early in the perioperative period to patients undergoing 
TKA is effective at reducing postoperative pain scores and reducing total opioid 
requirement during the postoperative period.  We hypothesize that patients who received 
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a single dose of dexamethasone, 8 mg, intraoperatively will have lower pain scores and a 
decrease in opioid consumption during the first three postoperative days.  
 
Methods 
Study Type and Population 
Following Institutional Review Board approval, a retrospective chart review was 
conducted comparing postoperative pain scores and opioid consumption following a total 
knee arthroplasty at a center with a high volume of total joint arthroplasty procedures.  
American Society of Anesthesiologists (ASA) physical status I, II, and III patients who 
underwent total knee arthroplasty from July 2013 to December 2013 were placed into 
two groups. The treatment group included patients who had received intraoperative 
dexamethasone 8 mg intravenously and the control group included patients who did not 
receive dexamethasone during the TKA.  
The study population was comprised of a convenience sample of all patients 
undergoing TKA at the institution during this time interval. A total of 102 patients 
underwent TKA, 55 subjects received dexamethasone (treatment group) and 47 did not 
(control group).  The dose of dexamethasone used in this study was based on the standard 
dose given to patients at this institution. All patients in this study received a single dose 
of 8 mg of dexamethasone intra-operatively, and did not receive any more during the 
remainder of their hospital stay. 
 
Study Criteria 
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Other inclusion criteria were age greater than 18 years, and either spinal or general 
anesthesia. Patients with type 1 diabetes or a history of substance abuse were excluded.  
Three patients were excluded from the study during the data collection process.  The first 
patient was excluded because he underwent bilateral knee arthroplasty. This patient 
received much more opioids when compared to the patients who had a single knee 
arthroplasty. The second patient was excluded because he received a dose of Ketamine®, 
which has analgesic properties. The last patient excluded received multiple doses of 
dexamethasone immediately post-operatively and through his/her hospital stay for the 
treatment of nausea. 
 
Data Collection 
Data collected from the electronic medical record (EMR) included patient’s age, sex, 
ASA score, height, weight, anesthesia technique (spinal versus general), dexamethasone 
dose, and postoperative analgesia. Where patient controlled analgesia (PCA) was used, 
the drug, basal rate, demand dose, total dose and any supplemental narcotics received 
(intravenous and oral) were recorded. The total dose of narcotics received was converted 
to morphine dose equivalents (DE) (DE, 1 DE = 10 mg morphine, using the McPhearson 
opioid conversion calculations chart).  Pain scores were recorded (using the 0-10 
Numerical Ratings Scale [NRS]) at the following intervals: preoperatively, immediately 
post- operatively, 12 hours postoperatively, 24 hours postoperatively, and 48 hours 
postoperatively, as this is standard protocol in our institution. 
Postoperative pain scores were compared between the groups along with the total 
amount of opioid use for pain relief. Opioid intake during the intraoperative period and 
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all administered analgesics were accounted throughout the patient’s hospital experience, 
up to time of discharge.  This included review of analgesia type and doses needed post 
operatively in the recovery area, as well as medications administered on subsequent 
postoperative days. 
 
Statistical Analysis 
The primary outcome variable was reported pain scores throughout the standard post-
operative hospital stay following total knee arthroplasty. A secondary outcome variable 
was total morphine dose equivalents. These variables were compared using independent 
t-tests.  Demographic and baseline data were analyzed using two sample t-test for 
continuous data and chi square for categorical data to determine if there were any 
differences between groups.  All statistical tests were two-tailed and the alpha level was 
set at 0.05%.  
 
Results 
No significant difference was noted between the groups with regards to age, gender, 
weight and height. Administration of either general and spinal anesthesia were evenly 
distributed between the groups, therefore differences in methods of anesthesia was not a 
statistically significant factor (Table 1, 2).  Immediate postoperative pain scores were 
compared according to the specific anesthetic received.  However, at the 12-hour mark 
the spinal and general anesthesia groups were combined, due to the negligible analgesic 
effect of spinal anesthesia 12-hours post administration.  Both the therapeutic and control 
groups of the study received standard IV patient-controlled analgesia, which was 
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discontinued 24 hours post-operative. There was no statistical difference noted in the 
prescribed dosing regimen between the groups for the standardized PCA dosing 
(P=0.68).  
 
Narcotic Consumption 
Patients who received dexamethasone required significantly less oral opioids (oral 
morphine equivalence 37.1 mg) compared to the control group (73.1 mg, P=0.020) 
throughout the standard three-day hospital stay (Fig. 1).  
 
Pain Scores 
No statistically significant difference was noted in immediate postoperative NRS pain 
scores upon arrival to the post-anesthesia care unit (PACU), at 12 hours and 48 hours.  
Although, at 24 hours the NRS pain scores were less for the dexamethasone group (4.57) 
than that of the control group (6.077) (P=0.003, Fig. 2).   
 
Discussion 
This study evaluated dexamethasone as a modality to decrease pain immediately 
postoperatively, at 12 hours, 24 hours, and 48 hours following a TKA.  In our 
retrospective study, we found a significant difference in the amount of oral narcotics used 
by the treatment group (P=0.020) throughout the standard three-day hospital stay, and 
pain scores at 24 hours postoperatively were significantly lower in the treatment group 
(P=0.003).  However, immediately after surgery, at 12 hours and at 48 hours there was no 
difference noted in NRS pain scores, indicating the greatest analgesic effect of 
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intraoperative dexamethasone dosing in this study was noted within the initial 24 hour 
time period.  This may be contributed to the nature of the dosing and/or the mechanism of 
action of the medication resulting in a delayed clinical response.  Alterations in the dosing 
regimen or different glucocorticoids or varying chemical properties, may alter the 
clinically effective analgesic window.  This is the only study in the medical literature 
known to use this standard dosing regimen of dexamethasone.  A similar study was 
completed with dosing of 10 mg of IV dexamethasone prior to incision, with standard 
administration of ondansetron in all patients8.  The effect of ondansetron has been known 
to have a clinically significant effect on the efficacy of pain medications in the 
perioperative period; therefore standard administration of this medication likely skewed 
the perception of pain9-11. This study did not include the administration of ondansetron as 
standard protocol, therefore the true analgesic effects of dexamethasone may have been 
better demonstrated in this study. 
The authors call for increased research in this field, to enhance to clinical effects as 
demonstrated in this paper.  Decreasing pain with intra-operative dexamethasone 
administration will reduce opioid consumption and reduce pain scores post-operatively as 
proven by this paper.  This correlates to increased patient satisfaction, decrease strain on 
hospital staff in treating pain, and decreased medical costs. 
This study is limited by its retrospective nature.  We depended on available 
documentation and could not control for confounding variables.  The proposed sample 
size was 125 subjects in each group to reach a power of 80% to detect a 0.35 difference 
in pain between groups, however, due to changes in medical record system we were 
unable to obtain the number of subjects needed to reach this level of power.  The small 
This article is protected by copyright. All rights reserved.
number of patients in this study is a limitation.  The groups were not matched, although 
there were no significant differences between the group demographics.  Due to the short 
half-life of fentanyl, we did not take into account the intraoperative doses.  This may 
have skewed the immediate postoperative pain scores, but is unlikely due to nature in 
which the medication was administered, the half-life of the drug, and the timeframe in 
which data was collected.  Other medications that were not accounted for in the morphine 
equivalents were preoperative Ultrium, Celebrex and Neurontin. All spinals in this study 
consisted of plain Marcaine, no epinephrine wash or added opioids.  To highlight the true 
efficacy of the dexamethasone, different doses could have also been analyzed to 
determine the ideal dose for an ideal response.  This study was limited that this analysis 
was not completed, and further studies should investigate this factor.  Pre-operative pain 
scores nor designated “knee scores” were not analyzed pre-operatively and compared 
post operatively, which could be compared to post-operative scores to give further details 
regarding the final data points.  Although this is a drawback to the study, the analysis of 
pain scores post-operatively and the random nature of patient group selection was felt to 
give clinically useful data regarding the use of dexamethasone in treating post-operative 
pain. 
 
Conclusion 
 
Literature suggests that the administration of dexamethasone decreases postoperative 
pain scores, reduces opioid consumption, and minimizes postoperative nausea and 
vomiting. All of these factors impact patient satisfaction, and most importantly, produce 
an overall positive postoperative outcome. In this study, we examined pain scores and 
opioid consumption in patients who received intraoperative dexamethasone.  We found 
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that a single dose of dexamethasone given intra-operatively significantly decreases oral 
narcotic consumption and decreased pain scores 24 hours postoperatively.  
Dexamethasone appears to be a safe modality to use to control pain in patients 
undergoing TKA.  Although many studies are proving the efficacy of dexamethasone in 
decreasing pain in many different surgeries, the ideal dose is yet to be found.  More 
studies are needed in the future to focus on an ideal regime, dosage and timing to 
optimize the clinical effects of this medication.  
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Figure Legends: 
Fig. 1 Opioids taken by patients in the control and treatment groups in morphine dose 
equivalence. 
Fig. 2 Pain NRS score of patients in the control and treatment group. 
TABLE 1 Baseline characteristics of the patients in the treatment and control 
groups 
   
Characteristics Control group 
(47 cases) 
Dexamethasone group 
(55 cases) Age (years) * Weight (kg) * Height (cm) * Gender (M/F) ASA physical status (I/II/III) 
62.6 ± 5.2 85.2 ± 9.9 165.1 ± 10.2 19/28 0/35/12 
64.8 ± 4.4 92.4 ± 10.5 158.9 ± 9.8 25/30 0/41/14 
* , Values are expressed as the mean ± standard deviation. 
 
 
TABLE 2 Anesthetic techniques between the treatment and control groups 
 
Anesthetic Control group 
(47 cases) 
Dexamethasone group 
(55 cases) Spinal  General  24 23 28 27  
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